Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5	8.74	12.62	13.16	63.46	16.46
Short-Term Investments	39.21	43.22	14.53	29.14	5.99	27.8
Cash & Short-Term Investments	44.21	51.96	27.15	42.3	69.45	44.26
Cash Growth	99.80%	91.40%	-35.82%	-39.09%	56.92%	-43.24%
Accounts Receivable	0.08	0.08	0.03	0.59	0.51	-
Other Receivables	-	0.14	0.04	0.05	0.03	0.09
Receivables	0.08	0.22	0.06	0.63	0.54	0.09
Prepaid Expenses	1.2	0.47	0.38	0.43	0.45	0.4
Other Current Assets	-	1.76	0.37	0.29	0.87	0.59
Total Current Assets	45.49	54.41	27.96	43.66	71.31	45.34
Property, Plant & Equipment	1.26	1.33	1.39	2.57	3.64	2.55
Long-Term Investments	12.06	12.54	16.12	21.88	34.27	37.23
Other Long-Term Assets	0.63	0.63	0.09	0.13	0.24	0.41
Total Assets	59.44	68.91	45.55	68.24	109.46	85.53
Accounts Payable	1.31	2.58	1.53	1.98	1.57	3.47
Accrued Expenses	3.87	3.44	3.73	7.39	6.96	7.42
Current Portion of Leases	0.32	0.19	1.37	1.23	1.05	1.08
Other Current Liabilities	3.78	29.2	0.25	0.16	0.12	0.18
Total Current Liabilities	9.28	35.4	6.87	10.75	9.69	12.15
Long-Term Leases	0.83	0.94	-	1.37	2.6	1.23
Total Liabilities	10.11	36.34	6.87	12.13	12.29	13.38
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	432.39	430.86	374.36	364.36	361.67	295.28
Retained Earnings	-381.82	-397.01	-334.72	-307.69	-266.38	-223.14
Comprehensive Income & Other	-1.25	-1.29	-0.97	-0.56	1.87	0
Total Common Equity	49.33	32.57	38.68	56.12	97.16	72.15
Shareholders' Equity	49.33	32.57	38.68	56.12	97.16	72.15
Total Liabilities & Equity	59.44	68.91	45.55	68.24	109.46	85.53
Total Debt	1.15	1.12	1.37	2.6	3.65	2.31
Net Cash (Debt)	43.06	50.84	25.78	39.7	65.8	41.95
Net Cash Growth	104.19%	97.25%	-35.08%	-39.67%	56.87%	-43.91%
Net Cash Per Share	0.65	0.83	0.54	0.85	1.57	1.42
Filing Date Shares Outstanding	68.17	68.14	49.04	46.57	46.55	38.31
Total Common Shares Outstanding	68.17	67.9	49.04	46.55	46.55	28.37
Working Capital	36.21	19.01	21.09	32.91	61.62	33.19
Book Value Per Share	0.72	0.48	0.79	1.21	2.09	2.54
Tangible Book Value	49.33	32.57	38.68	56.12	97.16	72.15
Tangible Book Value Per Share	0.72	0.48	0.79	1.21	2.09	2.54
Machinery	-	2.69	2.85	2.82	2.62	2.61
Leasehold Improvements	-	2.08	2.08	2.08	2.08	2.08

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q